Health Catalyst Inc (NASDAQ:HCAT) Stock Price Slipped -6.90% to $5.67
KeyBanc Capital Markets raised the price target for the Health Catalyst Inc (NASDAQ:HCAT) stock from “an Overweight” to “a Sector weight”. The rating was released on April 10, 2024, according to finviz. The research report from Barclays has initiated the stock to Overweight, with a price target set at $14. The stock was upgraded by […]
There Is Nothing Like Health Catalyst Inc (HCAT) Stock
Evercore ISI raised the price target for the Health Catalyst Inc (NASDAQ:HCAT) stock from “an In-line” to “an Outperform”. The rating was released on January 03, 2024, according to finviz. The research report from JP Morgan has upgraded the stock from Neutral to Overweight, with a price target set at $11. The stock was upgraded […]
There is no better tap than Health Catalyst Inc (HCAT) Stock
Evercore ISI raised the price target for the Health Catalyst Inc (NASDAQ:HCAT) stock from “an In-line” to “an Outperform”. The rating was released on January 03, 2024, according to finviz. The research report from JP Morgan has upgraded the stock from Neutral to Overweight, with a price target set at $11. The stock was upgraded […]
A Tale from the Dusty Corner: Health Catalyst Inc (HCAT) Stock
Evercore ISI raised the price target for the Health Catalyst Inc (NASDAQ:HCAT) stock from “an In-line” to “an Outperform”. The rating was released on January 03, 2024, according to finviz. The research report from JP Morgan has upgraded the stock from Neutral to Overweight, with a price target set at $11. The stock was upgraded […]
Health Catalyst Inc (HCAT) Stock is poised for a successful quarter
Evercore ISI raised the price target for the Health Catalyst Inc (NASDAQ:HCAT) stock from “an In-line” to “an Outperform”. The rating was released on January 03, 2024, according to finviz. The research report from JP Morgan has upgraded the stock from Neutral to Overweight, with a price target set at $11. The stock was upgraded […]
Health Catalyst Inc (HCAT) Stock is looking to regain its victory
Evercore ISI raised the price target for the Health Catalyst Inc (NASDAQ:HCAT) stock from “an In-line” to “an Outperform”. The rating was released on January 03, 2024, according to finviz. The research report from JP Morgan has upgraded the stock from Neutral to Overweight, with a price target set at $11. The stock was upgraded […]
